Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Myasthenia Gravis × Prednisolone × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Follicular 7 Neoplasm Metastasis 5 Ovarian Neoplasms 4 Lymphoma, Non-Hodgkin 3 Neoplasms 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, B-Cell 2 Lymphoma 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Recurrence 1 Prostate Cancer Metastatic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oral Ulcer 1 Myasthenia Gravis 1 Hodgkin Disease 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Bulbo-Spinal Atrophy, X-Linked 1 Biliary Tract Neoplasms 1 Advanced Cancer 1

Interventions

rozanolixizumab 9 efgartigimod alfa 7 zilucoplan 6 ravulizumab 5 eculizumab 5 fludarabine 4 Cyclophosphamide 4 telitacicept 3 Tacrolimus 3 HBM9161 3 inebilizumab 2 Amifampridine 2 satralizumab 1 rhoA GTP-Binding Protein 1 remibrutinib 1 iptacopan 1 Robotic Surgical Procedures 1 Prednisone 1 Prednisolone 1 Mycophenolic Acid 1 Diagnostic Self Evaluation 1 Data Collection 1 Cladribine 1 CK-2017357 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡